Natera, Inc.’s $100 Million Follow-On Public Offering

Davis Polk advised the several underwriters in connection with the follow-on offering of 5,263,158 shares of common stock of Natera, Inc. for total gross proceeds of approximately $100 million.

The shares are listed on the Nasdaq Global Select Market under the symbol “NTRA.”

J.P. Morgan Securities LLC, Cowen and Company, LLC, Piper Jaffray & Co., Robert W. Baird & Co. Incorporated and Canaccord Genuity LLC acted as underwriters in the deal.

Based in San Carlos, California, Natera is a diagnostics company with proprietary molecular and bioinformatics technology that it deploys to change the management of disease worldwide.

The Davis Polk corporate team included partner Alan F. Denenberg (Picture), counsel Jeffrey Gould and associates Dylan Service and Stephanie Y. Cheng. Partner Frank J. Azzopardi and associate Hilary Smith provided intellectual property and technology advice. Partner Rachel D. Kleinberg provided tax advice.

Involved fees earner: Frank Azzopardi – Davis Polk & Wardwell; Stephanie Cheng – Davis Polk & Wardwell; Alan Denenberg – Davis Polk & Wardwell; Jeffrey Gould – Davis Polk & Wardwell; Rachel Kleinberg – Davis Polk & Wardwell; Dylan Service – Davis Polk & Wardwell; Hilary Smith – Davis Polk & Wardwell;

Law Firms: Davis Polk & Wardwell;

Clients: Canaccord Genuity; Cowen and Company; J.P. Morgan Securities LLC; Piper Jaffray & Co; Robert W. Baird & Co.;

Author: Ambrogio Visconti